VAERS reports by lot

Merck HPV lot L043213: VAERS reports

83 VAERS reports list lot L043213 as a Merck HPV vaccine, received between 2016-03-09 and 2021-07-17. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
83
Reports
8%
Marked serious
0
With a death outcome
16
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
General / Systemic (non-local)1622%
Neurological1217%
Psychiatric / Neuropsychiatric912%
Cardiac / Cardiovascular811%
Allergic / Anaphylactic68%
Respiratory68%
Gastrointestinal68%
Injection-site / Local reaction57%
Musculoskeletal23%
Autoimmune / Immune-mediated11%
Reproductive / Menstrual11%

Where reports came from

U.S. state of the reporter, where given (top 12).

New York7
Michigan4
Texas3
Vermont3
Georgia3
Ohio3
New Jersey2
Pennsylvania2
Tennessee1
Massachusetts1
Louisiana1
District of Columbia1

Reports by month received

2016-036
2016-0412
2016-0517
2016-067
2016-0722
2016-083
2016-094
2016-123
2017-012
2017-021
2017-031
2017-051
2017-071
2017-101
2019-031
2021-071

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.